Organigram’s Q1 Revenue Drops 10% to CA$30 Million, Eyes German Exports
Organigram’s Q1 cannabis revenue fell 10% to CA$30 million, driving a CA$5 million net loss and compressing gross margin by 300 basis points. The company signed its first German distribution deal, targeting initial exports in Q3 2026.
1. Quarterly Financial Performance
In the first quarter, Organigram reported CA$30 million in cannabis sales, marking a 10% year-over-year decline. The top-line contraction led to a CA$5 million net loss and reduced gross margin by 300 basis points, reflecting pricing pressure and excess supply in the domestic market.
2. Germany Expansion Strategy
Organigram secured a distribution agreement to ship its products into Germany, aiming to diversify revenue streams. Initial exports are slated for Q3 2026, leveraging a partner network to establish a foothold in Europe and offset domestic sales headwinds.